Finance

Lists
Why is 300511 down 2,33%?
Dive Deeper
300511:SHE
Shanghai Xuerong Biotechnology Co Ltd
4,61 CN¥
-2,33%
(-0,11) 1D
15 қаз., 09:36:04 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300511...
Open
4,62 CN¥
High
4,66 CN¥
Low
4,60 CN¥
Mkt. cap
3,08 млрд
Avg. vol.
36,04 млн
Volume
1,60 млн
P/E ratio
20,30
52-wk high
8,50 CN¥
52-wk low
4,60 CN¥
EPS
0,23 CN¥
Shares outstanding
640,85 млн
No. of employees
2 мың
Open
4,62 CN¥
High
4,66 CN¥
Low
4,60 CN¥
Mkt. cap
3,08 млрд
Avg. vol.
36,04 млн
Volume
1,60 млн
P/E ratio
20,30
52-wk high
8,50 CN¥
52-wk low
4,60 CN¥
EPS
0,23 CN¥
Shares outstanding
640,85 млн
No. of employees
2 мың
News stories
From web sources and news partners
About Shanghai Xuerong Biotechnology Co Ltd
CEO-
Employees1,92 мың
Founded1995
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
534,26 млн
662,68 млн
678,92 млн
477,38 млн
Cost of goods sold
445,16 млн
506,32 млн
450,58 млн
577,16 млн
Cost of revenue
445,16 млн
506,32 млн
450,58 млн
577,16 млн
Research and development expenses
634,55 м.
976,13 м.
776,37 м.
1,23 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
36,26 млн
43,50 млн
34,05 млн
47,05 млн
Operating expense
42,33 млн
50,47 млн
39,79 млн
53,55 млн
Total operating expenses
487,49 млн
556,79 млн
490,37 млн
630,71 млн
Operating income
46,77 млн
105,89 млн
188,55 млн
-153,34 млн
Other non operating income
-151,07 м.
-425,46 м.
-5,97 млн
5,90 млн
EBT including unusual items
41,82 млн
94,64 млн
175,70 млн
-161,76 млн
EBT excluding unusual items
36,34 млн
93,84 млн
173,35 млн
-165,94 млн
Income tax expense
756,94 м.
15,39 мың
48,31 мың
163,44 м.
Effective tax rate
1,81%
0,02%
0,03%
-0,10%
Other operating expenses
5,19 млн
5,48 млн
5,15 млн
4,93 млн
Net income
40,20 млн
92,14 млн
173,17 млн
-155,32 млн
Net profit margin
7,53%
13,90%
25,51%
-32,54%
Earnings per share
-
-
-
-
Interest and investment income
-
380,11 м.
196,43 м.
1,10 млн
Interest expense
-10,04 млн
-16,04 млн
-9,42 млн
-9,74 млн
Net interest expenses
-10,04 млн
-15,66 млн
-9,23 млн
-8,64 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
139,31 млн
190,05 млн
272,71 млн
-69,55 млн
Gain or loss from assets sale
-12,82 млн
-16,31 млн
-
2,30 млн
AI content may include mistakes. Learn more
Google қолданбалары